data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Novartis
(NYSE:NVS)
$89.81
-0.01[-0.01%]
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$89.74
-0.0700[-0.08%]
PreMarket: 9:20AM EDT
Day Range- - -52 Wk Range74.09 - 94.26Open / Close- / -Float / Outstanding2.2B / 2.2B
Vol / Avg.- / 2.4MMkt Cap193.2BP/E9.2650d Avg. Price80.36
Div / Yield3.33/3.70%Payout Ratio34.28Total Float2.2BEPS0.73

Novartis Stock (NYSE:NVS), Quotes and News Summary

Novartis Stock (NYSE: NVS) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range74.09 - 94.26Open / Close- / -Float / Outstanding2.2B / 2.2B
Vol / Avg.- / 2.4MMkt Cap193.2BP/E9.2650d Avg. Price80.36
Div / Yield3.33/3.70%Payout Ratio34.28Total Float2.2BEPS0.73
Rachael Green -
Vandana Singh - Nov 23, 2022, 10:36AM
Vandana Singh - Nov 16, 2022, 11:23AM
Vandana Singh - Nov 14, 2022, 7:42AM
Vandana Singh - Oct 25, 2022, 5:51AM
Vandana Singh - Oct 24, 2022, 6:59AM
PRNewswire - Nov 21, 2022, 9:31AM
PRNewswire - Nov 9, 2022, 9:35AM
News Direct - Oct 18, 2022, 8:00AM
PRNewswire - Aug 8, 2022, 8:30AM
Globe Newswire - Jul 20, 2022, 9:00PM
Globe Newswire - Jul 15, 2022, 9:00PM
Newsfile - Jul 15, 2022, 12:00PM
Business Wire - Jul 15, 2022, 10:18AM
Business Wire - Jul 14, 2022, 7:22PM
PRNewswire - Jul 13, 2022, 9:06PM
PRNewswire - Jul 13, 2022, 11:30AM
Newsfile - Jul 11, 2022, 6:01PM
Globe Newswire - Jul 10, 2022, 9:00PM
PRNewswire - Jul 5, 2022, 11:24PM
Globe Newswire - Jul 4, 2022, 9:00PM
Globe Newswire - Jun 24, 2022, 9:00PM
Globe Newswire - Jun 23, 2022, 5:13PM
Globe Newswire - Jun 22, 2022, 7:00AM
Newsfile - Jun 15, 2022, 1:55PM
Globe Newswire - Jun 13, 2022, 9:00PM
Globe Newswire - Jun 13, 2022, 7:56PM
PRNewswire - Jun 8, 2022, 9:20PM
Globe Newswire - Jun 8, 2022, 9:00PM
Globe Newswire - Jun 3, 2022, 9:00PM
ACCESSWIRE - Jun 3, 2022, 3:00PM
Business Wire - Jun 2, 2022, 9:33PM
ACCESSWIRE - Jun 2, 2022, 3:50PM
Business Wire - Jun 1, 2022, 9:00PM
Globe Newswire - Jun 1, 2022, 4:45PM
Business Wire - Jun 1, 2022, 12:00PM
Business Wire - May 31, 2022, 6:00PM
Business Wire - May 31, 2022, 4:36PM
PRNewswire - May 26, 2022, 8:50AM
Globe Newswire - May 4, 2022, 4:01PM
COMSERVE - Mar 25, 2022, 4:04AM
Seeking Alpha - 1 day ago
InvestorsObserver - 1 day ago
InvestorPlace - Nov 24, 2022, 1:51AM
InvestorsObserver - Nov 23, 2022, 9:46AM
Seeking Alpha - Nov 23, 2022, 5:25AM
InvestorPlace - Nov 21, 2022, 10:37AM
Seeking Alpha - Nov 18, 2022, 3:55PM
InvestorsObserver - Nov 17, 2022, 2:00PM
Seeking Alpha - Nov 17, 2022, 9:36AM
InvestorsObserver - Nov 16, 2022, 9:24AM
Seeking Alpha - Nov 16, 2022, 8:09AM
Seeking Alpha - Nov 16, 2022, 4:52AM
Seeking Alpha - Nov 15, 2022, 4:43PM
InvestorsObserver - Nov 11, 2022, 10:37AM
Seeking Alpha - Nov 10, 2022, 7:15AM
InvestorsObserver - Nov 9, 2022, 2:23PM
Seeking Alpha - Nov 8, 2022, 9:00AM
InvestorsObserver - Nov 8, 2022, 8:12AM
Seeking Alpha - Nov 8, 2022, 5:22AM
InvestorsObserver - Nov 7, 2022, 2:47PM
Seeking Alpha - Nov 6, 2022, 12:00PM
Seeking Alpha - Nov 3, 2022, 10:04PM
InvestorsObserver - Nov 3, 2022, 3:20PM
Seeking Alpha - Nov 2, 2022, 1:37PM
InvestorsObserver - Nov 1, 2022, 3:29PM
Seeking Alpha - Nov 1, 2022, 6:03AM
Seeking Alpha - Oct 31, 2022, 9:21AM
InvestorsObserver - Oct 31, 2022, 9:13AM
Seeking Alpha - Oct 30, 2022, 9:28AM
InvestorsObserver - Oct 28, 2022, 3:31PM
StockNews - Oct 28, 2022, 11:22AM
Seeking Alpha - Oct 27, 2022, 3:50PM
Seeking Alpha - Oct 25, 2022, 1:42PM
StockNews - Oct 25, 2022, 7:58AM
Sector: Health Care.Industry: Pharmaceuticals
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-01
REV
Q3 2022Est.ActualSurprise
EPS1.5701.580 0.0100
REV12.990B12.543B-447.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Novartis (NVS) stock?

A

You can purchase shares of Novartis (NYSE: NVS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novartis's (NVS) competitors?

Q

What is the target price for Novartis (NVS) stock?

A

The latest price target for Novartis (NYSE: NVS) was reported by Wolfe Research on Monday, May 9, 2022. The analyst firm set a price target for 0.00 expecting NVS to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Novartis (NVS)?

A

The stock price for Novartis (NYSE: NVS) is $89.81 last updated December 1, 2022, 8:59 PM UTC.

Q

Does Novartis (NVS) pay a dividend?

A

A quarterly cash dividend of $2.18 per share of Class A Common Stock. The quarterly cash dividend was payable on March 17, 2022 to stockholders of record on March 8, 2022.

Q

When is Novartis (NYSE:NVS) reporting earnings?

A

Novartis’s Q4 earnings are confirmed for Wednesday, February 1, 2023.

Q

Is Novartis (NVS) going to split?

A

There is no upcoming split for Novartis.

Q

What sector and industry does Novartis (NVS) operate in?

A

Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.